Sinovac Biotech Ltd. (NASDAQ:SVA)

CAPS Rating: 2 out of 5

A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.

Recs

0
Player Avatar closetdoor (64.60) Submitted: 9/27/2006 5:38:33 PM : Outperform Start Price: $2.95 SVA Score: -44.92

speculative. this will do well in the near future

Featured Broker Partners


Advertisement